|
X4 Pharmaceuticals Inc (NASDAQ: XFOR) |
|
X4 Pharmaceuticals Inc
XFOR's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into X4 Pharmaceuticals Inc growth rates, revenue grew
in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 4
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 11.96 %
X4 Pharmaceuticals Inc realized net income compared to net loss a year ago in first quarter of 2025
• More on XFOR's Growth
|
|
X4 Pharmaceuticals Inc current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.
X4 Pharmaceuticals Inc PEG ratio is at -0.01
X4 Pharmaceuticals Inc realized cash reduction of $ -88.35 per share in trailing twelve-month period. |
Company |
0.79 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.02.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.2.
• More on XFOR's Valuation
|
|
|
|
|
X4 Pharmaceuticals Inc current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.
X4 Pharmaceuticals Inc PEG ratio is at -0.01
X4 Pharmaceuticals Inc realized cash outflow of $ -88.35per share in trailing twelve-month period. |
Company |
0.79 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.02.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.2.
X4 Pharmaceuticals Inc Price to Book Ratio is at 0.03 lower than Industry Avg. of 1880.05. and higher than S&P 500 Avg. of 0.01
• More on XFOR's Valuation
|
|
X4 Pharmaceuticals Inc net profit margin of 0.98 % is currently ranking no. 20 in Biotechnology & Pharmaceuticals industry, ranking no. 171 in Healthcare sector and number 2092 in S&P 500.
• More on XFOR's Key Ratios
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com